Clinical Trial Update: Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine and cisplatin as neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Urothelial Carcinoma | Phase 2 | Status: COMPLETED